After a major facelift, AltruBio says it’s ready for a pivotal fight against graft-versus-host disease

AltruBio got a makeover, and now it’s ready for its closeup.

CEO Judy Chou took over last January — when the biotech was still known as AbGemomics — on a mission to rebuild and rebrand. She culled the company’s oncology program to laser in on an old immunology candidate. Now...

Click to view original post